Health News

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced the publication of preclinical data in the Journal of Neuroimmunology finding that its lead development candidate VB-201 significantly delayed the onset and severity of experimental autoimmune encephalomyelitis (EAE) in mice, the commonly used Multiple sclerosis.

Read more

Filed under: Pharmacy News
Tags: cancer, Pharmacy, sclerosis

Related posts

• New Study Reveals UK Patients Are Less Likely To Receive Innovative Medicines (0)
  One of the most comprehensive reports comparing the use of medicines in the UK with that in other countries has been published by the Department of Health. The report shows that the UK still lags behind comparable countries in Europe and elsewhere on its use of newer cancer treatments and medicines for chronic diseases such [...]
  
  
• New Meds Faster (0)
  Biomolecules are medicine's jacks-of-all-trades: They are suitable for the diagnosis and treatment of cancer diseases; they are used in the treatment of multiple sclerosis and asthma; they help stimulate the build-up of the body's own immune defenses with flu and polio inoculations... Read more [tags] Pharmacy News [/tags]
  
  
• Medical Marijuana praises New Jersey State Assembly for removing state-wide penalties on marijuana use (0)
  Medical Marijuana Inc applauds the New Jersey State Assembly and Senate for having approved "The New Jersey Compassionate Use Medical Marijuana Act" on Monday, January 11, 2010. A804/S119 removes state-wide penalties for possession of up to two ounces of marijuana when a New Jersey licensed Physician recommends it for one of the qualified medical conditions [...]
  
  
• FDA approves cancer drug Afinitor for treatment of rare genetic disorder (0)
  The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery. Read more [tags] Pharmacy News [/tags]
  
  
• Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs (0)
  Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions. Read more [tags] Pharmacy News [/tags]